Motoneuron diseases are fatal neurodegenerative disorders characterized by a progressive loss of motoneurons, muscle weakness and premature death....
Array
(
[id_prestablog_news] => 583
[id_shop] => 1
[date] => 2014-04-24 00:00:00
[date_modification] => 2024-02-09 14:15:11
[langues] => ["1","2"]
[actif] => 1
[slide] => 0
[url_redirect] =>
[average_rating] =>
[number_rating] =>
[author_id] => 1
[featured] => 0
[prim_key] => 1142
[id_lang] => 2
[title] => Neurodegenerative changes are prevented by Erythropoietin in the pmn model of mo
[paragraph] => Neurodegenerative changes are prevented by Erythropoietin in the pmn model of motoneuron degeneration
[content] => Authors
M. Ruiz, A. F. Martínez-Vidala J. M. Morales, D. Monleón, M. Giménez et al.
Lab
Universidad Miguel Hernández (UMH), San Juan de Alicante, Spain
Journal
Neuropharmacology
Abstract
Motoneuron diseases are fatal neurodegenerative disorders characterized by a progressive loss of motoneurons, muscle weakness and premature death. The progressive motor neuronopathy (pmn) mutant mouse has been considered a good model for the autosomal recessive childhood form of spinal muscular atrophy (SMA). Here, we investigated the therapeutic potential of Erythropoietin (Epo) on this mutant mouse. Symptomatic or pre-symptomatic treatment with Epo significantly prolongs lifespan by 84.6% or 87.2% respectively. Epo preserves muscle strength and significantly attenuates behavioural motor deficits of mutant pmn mice. Histological and metabolic changes in the spinal cord evaluated by immunohistochemistry, western blot, and high-resolution 1H-NMR spectroscopy were also greatly prevented by Epo-treatment. Our results illustrate the efficacy of Epo in improving quality of life of mutant pmn mice and open novel therapeutic pathways for motoneuron diseases.
BIOSEB Instruments Used
Grip strength test (BIO-GS3)
[meta_description] =>
[meta_keywords] => http://www.sciencedirect.com/science/article/pii/S002839081400135X
[meta_title] =>
[link_rewrite] => neurodegenerative-changes-are-prevented-by-erythropoietin-in-the-pmn-model-of-motoneuron-degeneration
[actif_langue] => 1
[read] => 811
[count_comments] => 0
[id] => 583
[categories] => Array
(
[26] => Array
(
[id_prestablog_categorie] => 26
[title] => Domaines de recherche divers
[link_rewrite] => Domaines-de-recherche-divers
)
[2] => Array
(
[id_prestablog_categorie] => 2
[title] => Publications
[link_rewrite] => publications
)
)
[authors] =>
[paragraph_crop] => Neurodegenerative changes are prevented by Erythropoietin in the pmn model of motoneuron [...]
[link_for_unique] => 1
[products_liaison] => Array
(
[48] => Array
(
[name] => Test d'agrippement
[description_short] => Une méthode simple pour quantifier objectivement la force musculaire des rats et souris et l'effet de drogues, toxines, maladies musculaires (ex: myopathie) et neurodégénératives. Cette mesure de force est souvent employée en association avec le test de coordination motrice ROTAROD: un sujet présentant une coordination normale montrera des résultats médiocres en cas de faible force musculaire. Un must pour vos recherches sur l'activité, la coordination et le contrôle musculaire: particulièrement utile pour vos études sur les maladies de Parkinson et Huntington.
Nouveautés GS4 - 2023: Écran couleur rétroéclairé (meilleure lisibilité), pédale de remise à zéro, durée de batterie optimisée, taille de mémoire augmentée à 500 valeurs, compteur d'animaux, port USB (transfert de données/charge)


[thumb] =>
[img_empty] => /var/www/vhosts/de3310.ispfr.net/bioseb2024/modules/prestablog/views/img/product_link_white.jpg
[image_presente] => 1
[link] => https://bioseb.com/fr/activite-systeme-moteur-coordination/48-grip-strength-test.html
)
)
)
1 En lire plus